Literature DB >> 2269237

Family history of cancer and mortality among patients gastrectomized because of benign gastric diseases.

A Shibata1, A Asano, N Hamajima, R Sasaki, K Aoki, H Yokoyama, Y Yokoyama.   

Abstract

A preliminary result from a cohort study on the association of a family history of cancer with mortality is discussed in this paper. Among 2200 patients (1912 males and 288 females) gastrectomized because of benign gastric diseases, 274 male patients, and 40 female patients had a family history of cancer. During 2750 person-years of observation, 22 patients with the family history of cancer were found to be dead and 111 patients without the family history died during 17,527 person-years, giving a relative risk of 1.26 (not significant). We focused on the male subjects that were followed up for more than 10 years; however, the observed/expected ratio of cancer deaths for subjects with a family history of cancer was about four times higher than that for those without family history. Since case-control studies on family history are vulnerable to biased recall and interchangeability of cases, more cohort studies like the present study should be conducted to assess the association of the family history of cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2269237      PMCID: PMC1567848          DOI: 10.1289/ehp.908737

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  4 in total

1.  Genetic ascertainment with heterogeneous risk.

Authors:  E A Murphy; D A Meyers; C A Rohde
Journal:  Am J Med Genet       Date:  1987-07

Review 2.  Genetic epidemiology.

Authors:  M C King; G M Lee; N B Spinner; G Thomson; M R Wrensch
Journal:  Annu Rev Public Health       Date:  1984       Impact factor: 21.981

3.  The long-term prognosis of patients gastrectomized for benign gastroduodenal diseases.

Authors:  A Asano; S Mizuno; R Sasaki; K Aoki; H Yokoyama; Y Yokoyama
Journal:  Jpn J Cancer Res       Date:  1987-04

4.  Family history of cancer among cancer patients.

Authors:  H Ogawa; I Kato; S Tominaga
Journal:  Jpn J Cancer Res       Date:  1985-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.